[1]
“New Developments in the Front‑line Treatment of Advanced Stage Classic Hodgkin Lymphoma: A Canadian Perspective”, Can Hematol Today, vol. 4, no. 3, pp. 5–17, Dec. 2025, doi: 10.58931/cht.2025.4377.